BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9565158)

  • 1. Gene transfer for the eventual treatment of Fanconi's anemia.
    Liu JM
    Semin Hematol; 1998 Apr; 35(2):168-79. PubMed ID: 9565158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroviral-mediated transduction of the fanconi anemia C complementing (FACC) gene in two murine transplantation models.
    Liu JM; Kim S; Walsh CE
    Blood Cells Mol Dis; 1995; 21(1):56-63. PubMed ID: 7544677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy in the treatment of Fanconi anemia, a progressive bone marrow failure syndrome.
    Williams DA; Croop J; Kelly P
    Curr Opin Mol Ther; 2005 Oct; 7(5):461-6. PubMed ID: 16248281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for fanconi anemia.
    Croop JM
    Curr Hematol Rep; 2003 Jul; 2(4):335-40. PubMed ID: 12901331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent.
    Centurion SA; Kuo HR; Lambert WC
    Exp Cell Res; 2000 Nov; 260(2):216-21. PubMed ID: 11035916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice.
    Otsuki T; Nagakura S; Wang J; Bloom M; Grompe M; Liu JM
    J Cell Physiol; 1999 Apr; 179(1):79-86. PubMed ID: 10082135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular biology of Fanconi anemia.
    Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
    Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
    Noll M; Bateman RL; D'Andrea AD; Grompe M
    Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
    Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
    Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fanconi anemia: cellular and molecular features].
    Macé G; Briot D; Guervilly JH; Rosselli F
    Pathol Biol (Paris); 2007 Feb; 55(1):19-28. PubMed ID: 16904272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
    Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
    Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors.
    Aubé M; Lafrance M; Charbonneau C; Goulet I; Carreau M
    Stem Cells; 2002; 20(5):438-47. PubMed ID: 12351814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
    Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
    Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3R coordination by Fanconi anemia proteins.
    Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
    Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia.
    Auerbach AD
    Dermatol Clin; 1995 Jan; 13(1):41-9. PubMed ID: 7712649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four novel mutations of the Fanconi anemia group A gene (FAA) in Japanese patients.
    Nakamura A; Matsuura S; Tauchi H; Hanada R; Ohashi H; Hasegawa T; Honda K; Masuno M; Imaizumi K; Sugita K; Ide T; Komatsu K
    J Hum Genet; 1999; 44(1):48-51. PubMed ID: 9929978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.